Skip to main content

Table 1 The WPR rates for each antimicrobial

From: Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis

Antimicrobials

Breakpoint (mg/L)

Number of isolates tested

Number of resistant isolates n (%)

Weighted pooled resistance rate

95% Confidence interval

Heterogeneity

Metronidazole

>2

5900

190 (3.2)

0.01

0–0.03

91.97

Metronidazole

≥32

13,207

129 (1.0)

0.00

0–0.00

81.4

Vancomycin

≥32

2307

13 (0.6)

0.00

0–0.00

38.6

Vancomycin

≥16

2296

10 (0.4)

0.00

0–0.00

7.62

Vancomycin

≥4

1107

7 (0.6)

0.00

0–0.01

50.1

Vancomycin

>2

11,188

416 (3.7)

0.01

0–0.02

89.79

Moxifloxacin

≥8

11,484

3912 (34.1)

0.32

0.25–0.4

93.89

Meropenem

≥16

2756

20 (0.7)

0.00

0–0.01

71.49

Piperacillin/Tazobactam

≥128/4

3041

8 (0.3)

0.00

0–0.00

0

Clindamycin

≥8

19,645

6685 (34.0)

0.59

0.53–0.65

97.50

Ciprofloxacin

≥8

4339

3356 (77.0)

0.95

0.85–1.0

99.12

Tetracycline

≥16

4861

886 (18.2)

0.20

0.14–0.27

97.04

Amoxicillin/Clavulanate

≥16/8

2803

4 (0.1)

0.00

0–0.00

45.4

Ceftriaxone

≥64

3476

1289 (37.1)

0.47

0.29–0.65

99.05

Rifampin

>0.004

1861

787 (42.3)

0.37

0.18–0.58

97.69

Moxifloxacin

>4

2809

929 (33.1)

0.49

0.30–0.67

98.68

Tigecycline

>0.25

2375

39 (1.6)

0.01

0–0.03

83.53